# Vale S.A.: financial statements, quarterly

VALE · NYSE · CIK 917851 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vale.md) · [Financials](/companies/vale/financials.md) · [Filings](/companies/vale/filings.md) · [Insiders](/companies/vale/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vale/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2014-12-31) | period not labelled (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [4.0](/filings/0001047469-18-002777.md) | [3.6](/filings/0001047469-19-002391.md) | [4.3](/filings/0001047469-21-000687.md) | [5.8](/filings/0001047469-21-000687.md) | [5.8](/filings/0001104659-22-046078.md) | [7.4](/filings/0001292814-23-001516.md) | [13.5](/filings/0001292814-24-001463.md) | [11.7](/filings/0001292814-25-001137.md) | [4.7](/filings/0001292814-26-001844.md) | [3.6](/filings/0001292814-26-001844.md) | [5.0](/filings/0001292814-26-001844.md) | [7.4](/filings/0001292814-26-001844.md) |
| Current assets | $bn | not reported | not reported | [22.6](/filings/0001047469-18-002777.md) | [19.0](/filings/0001047469-19-002391.md) | [15.3](/filings/0001047469-20-002065.md) | [17.0](/filings/0001047469-21-000687.md) | [24.4](/filings/0001104659-22-046078.md) | [22.4](/filings/0001292814-23-001516.md) | [15.5](/filings/0001292814-24-001463.md) | [18.7](/filings/0001292814-25-001137.md) | [13.5](/filings/0001292814-26-001844.md) | [18.3](/filings/0001292814-26-001844.md) |
| Total assets | $bn | not reported | not reported | [99.0](/filings/0001047469-18-002777.md) | [99.2](/filings/0001047469-19-002391.md) | [88.2](/filings/0001047469-20-002065.md) | [91.7](/filings/0001047469-21-000687.md) | [92.0](/filings/0001104659-22-046078.md) | [89.4](/filings/0001292814-23-001516.md) | [86.9](/filings/0001292814-24-001463.md) | [94.2](/filings/0001292814-25-001137.md) | [80.2](/filings/0001292814-26-001844.md) | [86.5](/filings/0001292814-26-001844.md) |
| Current liabilities | $bn | not reported | not reported | [11.2](/filings/0001047469-18-002777.md) | [13.1](/filings/0001047469-19-002391.md) | [9.1](/filings/0001047469-20-002065.md) | [13.8](/filings/0001047469-21-000687.md) | [14.6](/filings/0001104659-22-046078.md) | [15.2](/filings/0001292814-23-001516.md) | [13.9](/filings/0001292814-24-001463.md) | [14.7](/filings/0001292814-25-001137.md) | [13.1](/filings/0001292814-26-001844.md) | [15.9](/filings/0001292814-26-001844.md) |
| Total liabilities | $bn | not reported | not reported | [58.0](/filings/0001047469-18-002777.md) | [54.4](/filings/0001047469-19-002391.md) | [43.4](/filings/0001047469-20-002065.md) | [52.7](/filings/0001047469-21-000687.md) | [57.2](/filings/0001104659-22-046078.md) | [54.1](/filings/0001292814-23-001516.md) | [49.5](/filings/0001292814-24-001463.md) | [53.2](/filings/0001292814-25-001137.md) | [45.6](/filings/0001292814-26-001844.md) | [52.2](/filings/0001292814-26-001844.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [56.3](/filings/0001047469-18-002777.md) | [35.7](/filings/0001047469-19-002391.md) | [39.0](/filings/0001047469-18-002777.md) | [43.5](/filings/0001047469-19-002391.md) | [44.0](/filings/0001047469-20-002065.md) | [40.1](/filings/0001047469-21-000687.md) | [35.7](/filings/0001104659-22-046078.md) | [34.5](/filings/0001292814-23-001516.md) | [35.9](/filings/0001292814-24-001463.md) | [39.5](/filings/0001292814-25-001137.md) | [33.4](/filings/0001292814-26-001844.md) | [33.5](/filings/0001292814-26-001844.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 3,256,724,482 at 2012-12-31, from the cover of the [20-F filed 2013-04-02](/filings/0001047469-13-003771.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.